CRISPR Therapeutics (CRSP) Sees IPO Price of $15 - $17/Share

CRISPR Therapeutics AG (Nasdaq: CRSP) filed an amended registration with the U.S. SEC for an initial public offering of its common stock. The company plans to sell 4.7 million shares and sees an offering price of $15 to $17 per share.

The offering is being made through Citigroup, Piper Jaffray, Barclays, and Guggenheim Securities.

CRISPR Therapeutics is a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics.

You May Also Be Interested In

• Karman Line Acquisition closes $200M IPO on Nasdaq
• QNB Corp. launches common stock offering, plans Nasdaq listing
• SpaceX held talks to acquire AI coding startup Cognition - report